It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2002.
2002 | Chennai, Tamil Nadu, India | ActiveCeras Pharmaceuticals Private Limited, a active private limited company, was established on 24 April 2002 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231TN2002PTC048824. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.75 M.
It upholds a compliant status. Employing 9 professional, Its leadership includes Archana Sudarshan (Director), Mahadevan Jayachanthrran (Whole-Time Director). Past directors included Venkata Narasimhan, Jayalakshmi Mahadevan. It holds ₹0.44 M open charges and ₹0.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.23, First Floor, Jawahar Nagar, 13Th Cross Street, Near Lakshmi Nagar, Porur, Chennai, Tamil Nadu, 600116.
U24231TN2002PTC048824
048824
24 April 2002
₹1.00 M
₹0.75 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Ceras Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archana Sudarshan | Director | 14 Sep 2014 | Current |
| Mahadevan Jayachanthrran | Whole-Time Director | 24 Apr 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 26 Dec 2008 | Past |
| Pramod Abcsdd | Director | 14 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ceras Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.65% increase. The company also saw a substantial improvement in profitability, with a 38.16% increase in profit. The company's net worth moved up by a moderate rise of 7.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ceras Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹440,000.00
₹500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2025 | Indian Overseas Bank | ₹0.44 M | Open |
| 14 Aug 2015 | Indian Overseas Bank | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Ceras Pharmaceuticals has a workforce of 9 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ceras Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ceras Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 14 Aug 2015 via Charge ID 10588919 with Indian Overseas Bank was fully satisfied on 22 Apr 2025. was recorded as a recent event.
Progress on A charge with Indian Overseas Bank amounted to Rs. 0.44 M with Charge ID 101095266 was registered on 15 Mar 2025. was documented.
Ceras Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Ceras Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on A charge with Indian Overseas Bank amounted to Rs. 0.50 M with Charge ID 10588919 was registered on 14 Aug 2015. was documented.
Progress on Archana Sudarshan was appointed as a Director was appointed as a Director on 14 Sep 2014 & has been associated with this company since 11 years 2 months . was documented.
The CIN of Ceras Pharmaceuticals Private Limited is U24231TN2002PTC048824.
Ceras Pharmaceuticals Private Limited is headquartered at No.23, First Floor, Jawahar Nagar, 13Th Cross Street, Near Lakshmi Nagar, Porur, Chennai, Tamil Nadu, 600116.
Ceras Pharmaceuticals Private Limited was incorporated on 24 April 2002.
The current directors of Ceras Pharmaceuticals Private Limited are
The primary industry of Ceras Pharmaceuticals Private Limited is Trade.
Ceras Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ceras Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.75 M.
The compliance status of Ceras Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX